VYNE compared with EOLS: revenue, margins and what each company keeps, and the suppliers and customers both name

VYNEVYNE Therapeutics Inc.

Mkt capRevenueRevenue

EOLSEvolus, Inc.

Mkt capRevenueRevenue

Compare

VYNEVYNE Therapeutics Inc.

EOLSEvolus, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

VYNE revenue flow unavailable. EOLS: latest quarter is a loss; flow not drawable.Method ›

VYNEVYNE Therapeutics Inc.

17.86▼−0.38%· post 17.27

Mkt cap—Revenue—Revenue—

EOLSEvolus, Inc.

7.38▲+3.00%· post 7.38

ClosedNov 3 '26

Mkt cap$486.8MRevenue$84MQ2 FY26Revenue$297MFY25

Compare

ClosedNov 3 '26

VYNEVYNE Therapeutics Inc.

EOLSEvolus, Inc.

17.86▼−0.38%post 17.27

Price

7.38▲+3.00%post 7.38

—

Mkt cap

$486.8M

—

Revenue

$84MQ2 FY26

—

Revenue

$297MFY25

VYNE17.86▼−0.38%vsEOLS7.38▲+3.00%ClosedNov 3 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VYNE 0

None

Shared 0

No disclosed counterparties: VYNE.

Only EOLS 3

—Daewoong Pharmaceuticalsunlistedsupplier

—Symateseunlistedsupplier

—Symatese Aesthetics S.A.Sunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

VYNE, solidEOLS, dashed